Atara Biotherapeutics
ATRA
$0.69
Share price
-2.35%
Change (1 day)
-66.99%
Change (1 year)
Categories
Atara Biotherapeutics (ATRA) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $0.26 B
According to Atara Biotherapeutics's latest financial reports the company's total liabilities are $0.26 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Atara Biotherapeutics - Total liabilities on balance sheet (from 2013 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $0.24 B | 32.5% |
| 2021-12-31 | $0.18 B | 49.87% |
| 2020-12-31 | $0.12 B | 141.14% |
| 2019-12-31 | $52.16 M | -1.55% |
| 2018-12-31 | $52.98 M | 32.74% |
| 2017-12-31 | $39.91 M | 292.17% |
| 2016-12-31 | $10.17 M | 3.07% |
| 2015-12-31 | $9.87 M | 235.88% |
| 2014-12-31 | $2.94 M | -95.32% |
| 2013-12-31 | $62.84 M | 683.9% |
| 2012-12-31 | $8.01 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 ImmunoGen
IMGN | $0.26 B | -1.60% | 🇺🇸 USA |
 Agenus
AGEN | $0.46 B | 74.63% | 🇺🇸 USA |
 Affimed
AFMD | $43.5 M | -83.57% | 🇩🇪 Germany |